The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2016: Volume 21/ Issue 1 Article 3
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 21, Issue 1, 07 January 2016
Rapid communication
Berry, Fillaux, Martin-Blondel, Boissier, Iriart, Marchou, Magnaval, and Delobel: Evidence for a permanent presence of schistosomiasis in Corsica, France, 2015

+ Author affiliations

Citation style for this article: Berry A, Fillaux J, Martin-Blondel G, Boissier J, Iriart X, Marchou B, Magnaval JF, Delobel P. Evidence for a permanent presence of schistosomiasis in Corsica, France, 2015. Euro Surveill. 2016;21(1):pii=30100. DOI:

Received:10 December 2015; Accepted:05 January 2015

We report a case of schistosomiasis acquired in 2015 in Corsica, indicating that permanent transmission of this helminthiasis has been established on the island.

Case description

On 11 September 2015, a person in their 40s presented to the Consultation Board at the Infectious and Tropical Disease Department of Toulouse University Hospitals in France with a 15-day history of diffuse abdominal pain, headache and asthenia. The patient had no fever, and physical examination was unremarkable. In particular, the patient neither displayed any skin rash nor complained of pruritus. The white blood cell count was 6.0 × 109/L, within the normal range (4.0–10.0 × 109 cells/L), but a blood eosinophilia (3.2 × 109 cells/L, normal range: < 0.5 × 109 cells/L) was observed by differential count. Biochemical tests of liver function found several abnormalities, namely a serum alanine aminotransferase level at 140 UI/L (normal range: 0–40 UI/L) and a gamma-glutamyl transferase level at 323 IU/L (normal range: 0–60 IU/L). Aspartate aminotransferase and total bilirubin levels were within the normal range. C-reactive protein was 11.7 mg/L (normal value: < 5 mg/L).

By serology, the patient tested negative for cytomegalovirus, Epstein–Barr virus, hepatitis A, B and C, and Leptospira infections. Serodiagnostics of ascariasis, alveolar and cystic echinococcoses, fascioliasis, filariases, strongyloidiasis, trichinellosis and schistosomiasis were negative. The ELISA result for schistosomiasis (expressed as a ratio), although negative with a ratio of 0.770, was close to the cut-off value of 1.0. Schistosomiasis serology relied upon commercial ELISA kits (Bordier Affinity Products, Crissier, Switzerland) and indirect haemagglutination assay (IHA) (Fumouze Diagnostics, Levallois-Perret, France), which are both screening tests using Schistosoma mansoni extracts as antigen.

Because an aetiological diagnosis was not reached, the patient attended a further consultation on 24 September. The clinical picture remained unchanged, but blood eosinophilia decreased to 2 × 109 cells/L. By that time, specific laboratory examinations for urogenital schistosomiasis had been carried out because of the previous ELISA result and also because the patient informed us of their vacation in Corsica in summer 2015. Urinalysis was normal, and microscopic search for Schistosoma haematobium eggs remained negative. Serology was positive, with an ELISA ratio of 2.65 (cut-off: 1.0). The IHA result (expressed as a titre of dilution) was 160 (cut-off: 160). These results were checked by a commercial Western blot using a mixture of adult S. haematobium and S. mansoni antigens (SCHISTO II Western blot IgG, LDBIO Diagnostics, Lyon, France). Faintly positive bands were observed at 30 kDa and 34 kDa, a result which was specific for the Schistosoma genus.

On 15 October, the patient was asymptomatic, the eosinophil count had decreased to 0.5 × 109 cells/L and hepatic tests were back to normal values. The level of Schistosoma-specific antibodies, as measured by ELISA (ratio: 4.67) or IHA (titre: 320) had increased. At that point, the Western blot result was clearly positive, with two sharp bands at 30 and 34 kDa. Results of immunodiagnoses for other helminthiases (see above) remained negative.

On 26 October, the patient attended the Consultation Board for the last time and received a single 40 mg/ kg dose of praziquantel. Microscopic examination of the sediment from the whole-morning micturition failed again to find any S. haematobium eggs.

The course of clinical signs and laboratory results is displayed in the Table.


Chronology of events and laboratory results

Date (2015) 30 July and 11 August From 24 August 30 August 7 September 11 September 24 September 15 October 26 October
Event Bathing in the Cavu River None MCa MCa MC MC MC MC
Symptoms and treatment ND Abdominal pain and headache Idem Idem Idem Decreasing symptoms No symptoms Praziquantel, 40 mg/kg once
Eosinophil count (G/L) ND ND 0.67 2.0 3.2 2.0 0.5 NA
ELISAb (cut-off: 1.0) ND ND NA NA 0.77 2.65 4.67 NA
IHAc (cut-off: 160) ND ND NA NA Negative 160 320 NA
Western blotd (kDa bands) ND ND NA NA Negative 30 /34 (faint) 30/34 NA
Urinary sediment examination ND ND NA NA NA NA Normal Normal
S. haematobium eggs in urine ND ND NA NA NA NA Negative Negative

ELISA: enzyme-linked immunosorbent assay; IHA: indirect haemagglutination assay; NA: not available; ND: not done.

a Medical consultations outside the Department of Infectious and Tropical Diseases.

b ELISA using extracts from adult worms and eggs of Schistosoma mansoni (Bordier Affinity Products, Crissier, Switzerland).

c Indirect haemagglutination using S. mansoni adult worm extracts (Fumouze Diagnostics, Levallois-Perret, France).

d Western blot using extracts from adult S. haematobium/S. mansoni worms (LDBIO Diagnostics, Lyon, France). Detection of genus-specific bands.

During the last consultation, the patient reported bathing twice for more than one hour in the Cavu River on 30 July and 11 August 2015. The patient had not been bathing in other rivers in Corsica and had no previous history of staying in or travelling to any classic or usual endemic area for schistosomiasis.

The patient’s family (four persons) had also been bathing in the Cavu River at the same time, but for a shorter time. Three had unremarkable laboratory results and one child had discrepant immunodiagnostic results for schistosomiasis with a positive ELISA (ratio: 1.53), a negative IHA (titre: 80) and a negative Western blot (performed on 26 October). Because of the unclear result, this child was treated with a single dose of praziquantel (40 mg/kg) and serology will be repeated three months later to confirm or exclude the diagnosis of schistosomiasis.


Here we present a case of schistosomiasis very probably acquired through bathing in the Cavu River in Corsica in summer 2015. Although microscopical examination of the patient's urine failed to find S. haematobium eggs, the combination of clinical symptoms, a transient blood eosinophilia, positive results from three immunodiagnostic tests (two screening tests and one confirmatory test), along with the kinetics of anti-Schistosoma antibodies consistent with a seroconversion, presented a syndrome that was diagnosed as acute schistosomiasis. Furthermore, the patient did not report any history of bathing in other Rivers in Corsica or staying in or travelling to classic or usual endemic areas for schistosomiasis. Previously, an outbreak of urogenital schistosomiasis had been identified in connection with bathing in the same river during the summer of 2013 [1-5]. That no schistosomiasis infections were observed in the 2014 summer is probably due to the fact that the French authorities prohibited bathing in the Cavu River. This ban had been lifted by spring 2015.

In 1966, Jean-Marie Doby, a French parasitologist, stated that Corsica met all the requirements for permanent transmission of urogenital schistosomiasis [6]. This became true nearly 50 years later when more than 120 cases of autochthonous schistosomiasis were diagnosed in France. All these infections were acquired after bathing in the Cavu River in southern Corsica and all were consistent with an infection during summer 2013 [1-5]. Transmission occurring before and after 2013 has been reported in two articles [7,8]. However, in both series, the diagnosis of schistosomiasis was questionable in our view, since it relied only upon conflicting serological results that were not followed up by a second test [9].

The present case who got infected in summer 2015 raises the question about the parasite's origin. The hypothesis of an aetiological link between the 2013 outbreak and the present case is attractive, although the lack of molecular evidence makes this assumption purely speculative. If true, the parasite would have survived either in an infected human or in the environment, in an intermediate mollusk host or a domestic or wild mammal definitive host.

The hypothesis of an independent introduction to the same river by an infected person coming from an endemic country, appears unlikely. However, the hypothesis of an environmental reservoir also appears unlikely. The time between the first contaminations in August 2013 and the present case was ca 24 months, including two winter seasons. Although nothing is known of the persistence of Schistosoma in cold conditions, such a period seems too long for the parasite to persist inside a mollusk host. Indeed, mollusks from the Cavu River that were experimentally infected by low inoculums of the Corsica strain of S. haematobium survived up to nine months in laboratory conditions (25 °C constant temperature and ad libitum feeding). Moreover, since the Corsica strain is a hybrid form between human and bovine Schistosoma [10], potential animal reservoir hosts have been screened for Schistosoma infections. Ruminants (cows and goats) that grazed along the Cavu River tested negative for Schistosoma infection. Trapped rodents were also found free of blood flukes (data not shown).

The most likely hypothesis is that people who were initially infected in 2013 in the Cavu River re-seeded the waterway with blood flukes by urinating. This suggests that the wide-scale screening of more than 37,000 people in France [6] did not identify all human carriers shedding Schistosoma eggs. If that is the case, it is possible that schistosomiasis could be spread to other rivers in Corsica, and to all of southern Europe (continental France, Spain, Portugal, Italy, and Greece) where the snail intermediate host is present.


Permanent transmission of schistosomiasis in Corsica is a new challenge for the French and European health authorities, whose goals should be to improve the effectiveness of screening and consecutive treatment of the infected, and to list any new case of autochthonous schistosomiasis. These measures will improve control of the initial focus and may prevent a possible expansion of urogenital schistosomiasis across southern Europe. General practitioners and specialists should become aware that schistosomiasis is not exclusively a tropical disease but has to be added to other possible aetiologies of blood eosinophilia or haematuria, even in patients without a history of staying in Africa or the Middle East.

Physicians should also be reminded that the pre-patent period of the infection, during which serological tests are still negative, may last for more than three months [11] and that seroconversion such as assessed by Western blot could be delayed when compared with the results provided by ELISA or IHA screening tests.

Conflict of interest

None declared.

Authors’ contributions

All authors were involved in the case investigation and contributed to the manuscript. This included expertise in infectious diseases (GMB, BM, PD), parasitology (AB, JF, JB, JFM, XI), diagnosis (AB, JF, XI, PD), and drafting the manuscript (AB, JF, JB, JFM, PD).


  1. Holtfreter MC, Moné H, Müller-Stöver I, Mouahid G, Richter J. Schistosoma haematobium infections acquired in Corsica, France, August 2013.Euro Surveill. 2014;19(22):20821. DOI: 10.2807/1560-7917.ES2014.19.22.20821 PMID: 24925456

  2. Berry A, Moné H, Iriart X, Mouahid G, Aboo O, Boissier J,  et al.  Schistosomiasis haematobium, Corsica, France. Emerg Infect Dis. 2014;20(9):1595-7. DOI: 10.3201/eid2009.140928 PMID: 25153697

  3. Brunet J, Pfaff AW, Hansmann Y, Gregorowicz G, Pesson B, Abou-Bacar A,  et al.  An unusual case of hematuria in a French family returning from Corsica. Int J Infect Dis. 2015;31:59-60. DOI: 10.1016/j.ijid.2014.10.024 PMID: 25461660

  4. Patard PM, Debuisson C, Mouttalib S, Berry A, Garnier A, Galinier P,  et al.  [Urinary schistosomiasis contracted in a child in Corsica]. Arch Pediatr. 2015;22(3):327-8. DOI: 10.1016/j.arcped.2014.11.023 PMID: 25617056

  5. Haut Conseil de la santé publique (HCSP). Avis relatif à la surveillance nationale des cas autochtones de bilharziose urogénitale. [Notice regarding national surveillance of autochthonous cases of urogenital schistosomiasis]. Paris: HCSP; 2015. French. Available from:

  6. Doby JM, Rault B, Deblock S, Chabaud A. [Snails and bilharziasis in Corsica. Distribution, frequency and biology of "Bulinus truncatus"]. Ann Parasitol Hum Comp. 1966;41(4):337-49. French.PMID: 6008534

  7. Beltrame A, Zammarchi L, Zuglian G, Gobbi F, Angheben A, Marchese V,  et al.  Schistosomiasis screening of travelers from Italy with possible exposure in Corsica, France. Emerg Infect Dis. 2015;21(10):1887-9. DOI: 10.3201/eid2110.150869 PMID: 26401824

  8. Gautret P, Mockenhaupt FP, von Sonnenburg F, Rothe C, Libman M, Van De Winkel K,  et al.  Local and International Implications of Schistosomiasis Acquired in Corsica, France. Emerg Infect Dis. 2015;21(10):1865-8. DOI: 10.3201/eid2110.150881 PMID: 26401954

  9. Berry A, Paris L, Boissier J, Caumes E. Schistosomiasis screening of travelers to Corsica, France.Emerg Infect Dis. 2016;22(1):159. 10.1007/s00436-015-4643-4 PMID: 26268566

  10. Moné H, Holtfreter MC, Allienne JF, Mintsa-Nguéma R, Ibikounlé M, Boissier J,  et al.  Introgressive hybridizations of Schistosoma haematobium by Schistosoma bovis at the origin of the first case report of schistosomiasis in Corsica (France, Europe). Parasitol Res. 2015;114(11):4127-33. DOI: 10.1007/s00436-015-4643-4 PMID: 26268566

  11. Grandière-Pérez L, Ansart S, Paris L, Faussart A, Jaureguiberry S, Grivois JP,  et al.  Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers. Am J Trop Med Hyg. 2006;74(5):814-8.PMID: 16687686

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.